This application generally relates to micro-electromechanical devices and, in particular, to micro-electromechanical substance delivery devices and methods for controlled delivery of substances such as drugs and medication.
In recent years, there has been significant research and development in the biomedical field with regard to drug delivery devices and, in particular, implantable bio-compatible microchip drug delivery devices. In general, an implantable microchip drug delivery device includes an array of micro-scale reservoirs that are formed in a substrate. The reservoirs are filled with certain medications/drugs that are contained within the reservoirs using releasable membrane structures. The microchip drug delivery devices are designed with various types of actuation mechanisms that allow the contents of the reservoirs to be automatically released (via the releasable membrane structures) either continuously, periodically or “on demand” by an individual (e.g., doctor or patient). These actuation mechanisms generally include passive and active release mechanisms.
By way of example, with passive release mechanisms, porous releasable membrane structures can be utilized which allow the contents of the reservoirs to slowly diffuse out from the reservoirs. Alternatively, a passive release mechanism can be configured to deteriorate over time to release the reservoir contents. Furthermore, an example of an active release mechanism includes releasable membranes that are configured to rupture using electrical actuation mechanisms. In general, these active release mechanisms utilize a power source, such as a thin-film battery, to provide an electrical current and/or voltage that is sufficient to rupture or otherwise melt or vaporize a membrane structure to thereby provide controlled release of reservoir contents. When drug delivery over a long period of time is required, it is necessary to minimize the energy requirements for active release mechanisms to ensure proper device operation, as well as minimize any adverse impact of the power dissipation on the reservoir contents to be released as well as organism cell function. Although a variety of active reservoir release methods have been proposed, none of the proposed methods implement low-power release mechanisms for rupturing releasable structures.
In general, embodiments of the invention include electromechanical substance delivery devices and methods implementing low-power electromechanical release mechanisms for controlled delivery of substances such as drugs and medication. In one embodiment of the invention, an electromechanical device includes a substrate having a cavity formed in a surface of the substrate, a membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the membrane and the surface of the substrate. The seal surrounds the opening of the cavity, and the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure that is configured to locally heat a portion of the membrane in response to a control voltage applied to the electrode structure, and create a stress that causes a rupture in the locally heated portion of the membrane to release the substance from within the cavity.
In another embodiment of the invention, an electromechanical device includes a substrate having a cavity formed in a surface of the substrate, a membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the membrane and the surface of the substrate. The seal surrounds the opening of the cavity, and the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure having a first contact, a second contact, and a plurality of filaments arranged adjacent to each other. The plurality of filaments are electrically connected in parallel to the first and second contacts of the electrode structure, and the filaments are configured to melt in succession in response to a control voltage applied to the first and second contacts, and cause a rupture in a portion of the membrane adjacent to the plurality of filaments to release the substance from within the cavity.
In yet another embodiment of the invention, an electromechanical device includes a substrate comprising a cavity formed in a surface of the substrate, and a membrane disposed on the surface of the substrate covering an opening of the cavity. The membrane includes a plurality of voids formed within the membrane, wherein the plurality of voids are configured to reduce a strength of the portion of the membrane within which the voids are formed. A seal is disposed between the membrane and the surface of the substrate, wherein the seal surrounds the opening of the cavity, wherein the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure configured to thermally expand in response to a control voltage applied to the electrode structure and apply a tensile stress to the portion of the membrane within which the voids are formed and cause a rupture in said portion of the membrane to release the substance from within the cavity.
In another embodiment of the invention, an electromechanical device includes a substrate comprising a cavity formed in a surface of the substrate, a metallic membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the metallic membrane and the surface of the substrate, wherein the seal surrounds the opening of the cavity, and wherein the seal and metallic membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure configured to locally heat a portion of the metallic membrane in response to a control voltage applied to the electrode structure, and cause melting of the locally heated portion of the metallic membrane to release the substance from within the cavity.
In yet another embodiment of the invention, an electromechanical device includes a substrate comprising a cavity formed in a surface of the substrate, a membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the membrane and the surface of the substrate, wherein the seal surrounds the opening of the cavity, wherein the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure formed on the membrane, wherein the electrode structure is formed in a tensile-stressed state, and comprises a fuse portion. The membrane includes a plurality of voids formed within the membrane along one or more edges of the electrode structure, wherein the plurality of voids are configured to reduce a strength of a portion of the membrane along the one or more edges of the electrode structure. The fuse portion of the electrode structure is configured to melt in response to a control voltage applied to the electrode structure and cause the electrode structure to peel back and rupture the portion of the membrane in which the plurality of voids are formed along the one or more edges of the electrode structure.
In yet another embodiment of the invention, an electromechanical device includes a substrate comprising a cavity formed in a surface of the substrate, a membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the membrane and the surface of the substrate, wherein the seal surrounds the opening of the cavity, and wherein the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure configured to locally heat a least a portion of the seal in response to a control voltage applied to the electrode structure, and melt the locally heated portion of the seal to release the substance from within the cavity.
In another embodiment of the invention, an electromechanical device includes a substrate comprising a cavity formed in a surface of the substrate, a membrane disposed on the surface of the substrate covering an opening of the cavity, and a seal disposed between the membrane and the surface of the substrate, wherein the seal surrounds the opening of the cavity, and wherein the seal and membrane are configured to enclose the cavity and retain a substance within the cavity. The device further includes an electrode structure configured to locally heat a region in proximity to the seal in response to a control voltage applied to the electrode structure, and cause a mechanical stress that is effective to break at least a portion of the seal to release the substance from within the cavity.
These and other embodiments of the invention will be described or become apparent from the following detailed description of embodiments, which is to be read in conjunction with the accompanying drawings.
Embodiments of the invention will now be discussed in further detail with regard to microchip substance delivery devices having low-power electromechanical release mechanisms to provide controlled delivery of substances such as drugs and medication. In general, embodiments of the invention include electromechanical releasable membrane structures that incorporate microelectronic structures within a releasable membrane to effectively provide low-energy actuation mechanisms that allow precise control of the release location within the membrane. For example, embodiments of the invention include electrode structures that confine electrical current to small regions of a releasable membrane structure to cause localized heating within the small regions of releasable membrane structure. This localized heating introduces mechanical stress in the locally heated regions of the membrane to initiate membrane rupturing due to a highly localized thermal energy density, thereby providing a low-power actuation mechanism with precise control of the rupture location of the membrane.
As discussed in further detail below, the exemplary microchip substance delivery devices described herein can be constructed using standard MEMS (Micro-Electro-Mechanical-Systems) fabrication techniques, as well as wafer-level 3D fabrication and integration techniques, to construct a device substrate having array of micro reservoirs to store deliverable substances (such as drugs or medications), as well as to construct layered releasable membranes with integrated electrode structures to seal the deliverable substances within the cavities of the device substrate. Indeed, various components and structures of microchip substance delivery devices according to embodiments of the invention can be fabricated using a combination of standard processes, namely semiconductor lithography, MEMs processes, and low-temperature wafer-to-wafer three-dimensional silicon processes, and using standard materials and structures that are compatible with back-end-of-the-line (BEOL) processing, wafer bonding, wafer thinning, and wafer transfer processes.
It is to be understood that the various layers, structures, and regions shown in the accompanying drawings are not drawn to scale, and that one or more layers, structures, and regions of a type commonly used in microchip substance delivery devices may not be explicitly shown in a given drawing. This does not imply that the layers, structures, and regions not explicitly shown are omitted from the actual microchip substance delivery devices. Moreover, the same or similar reference numbers used throughout the drawings are used to denote the same or similar features, elements, or structures, and thus, a detailed explanation of the same or similar features, elements, or structures will not be repeated for each of the drawings.
The microchip substance delivery device 100 further comprises a membrane 120 disposed on the substrate 102 covering an opening of the cavity 104, and a seal 130 disposed between the membrane 120 and the surface 106 of the substrate 102. The seal 130 surrounds the opening of the cavity 104. The seal 130 and the membrane 120 are configured to enclose the cavity 104 and retain the substance 108 within the cavity 104. While only one cavity 104 is shown for illustrative purposes, it is to be understood that the substrate 102 may be formed with an array of cavities comprising hundreds of cavities that serve as reservoirs for holding the same type or a combination of different types of deliverable substances.
In addition, as collectively shown in
More specifically,
The first leg 142 extends from the first contact 146 and includes an end portion 142A that is thinner in width than the width of the first leg 142. Similarly, the second leg 144 extends from the second contact 148 and includes an end portion 144A that is thinner in width than the width of the second leg 142. The end portions 142A and 144A of the first and second legs 142 and 144 form an “apex” portion of the V-shaped electrode 142/144 which is configured to provide localized heating of the portion 150 of the membrane 120. More specifically, when a control voltage is applied to the first and second contacts 146 and 148, the current flow through the V-shaped electrode 142/144 will have a higher current density in the apex region 142A/144A because of the thinner width metallization pattern and the angled shape of the apex region 142A/144A. This higher current density in the apex region 142A/144A results in a high thermal density in the locally heated portion 150 of the membrane 120 surrounding the apex region 142A/144A. This localized high thermal density causes a mechanical stress in the locally heated portion 150 of the membrane 120 which is sufficient to rupture the membrane 120.
More specifically, the electrode structure 140 shown in
In one embodiment of the invention, the electrode structure 140 is designed so that the locally heated portion 150 of the membrane 120 has a lateral dimension that is less than about two times a thickness of the membrane 120. In other words, to achieve low-power release, the region of membrane 120 which is locally heated is restricted in size to an area much smaller than the size of the cavity 104 (which is in contrast to other release schemes that are designed to heat an area of the membrane which is the same as the area of the cavity opening). The size of the locally heated portion 150 of the membrane 120 (in relation to the thickness of the membrane 120) will vary depending on the material(s) used to form the membrane 120 and whether the membrane 120 is formed in a non-stressed state or a stressed state.
More specifically, in one embodiment of the invention, the membrane 120 can be formed in a non-stressed state (e.g., no tensile stress), such that rupture of the membrane 120 is caused by the mechanical stress that is induced in the membrane 120 by virtue of the localized heating of a small portion of the membrane, as discussed above. In addition, in the embodiment of
In another embodiment of the invention, low-power release is further achieved by forming one or more thin film layers (e.g., the silicon nitride layers 122, 124) of the membrane 120 in a state of internal tensile stress, which stresses the membrane 120 close to the elastic limit. In other words, the internal stress can be formed to a level that is close to, but does not exceed, a stress level which would cause spontaneous cracking and rupture of the membrane 120. By way of specific example, as shown in
As noted above, microchip substance delivery devices according to embodiments of the invention can be fabricated using standard materials and semiconductor fabrication processes, including MEMS technology, and BEOL, photolithography, wafer bonding, wafer thinning, and wafer transfer processes, for example. Moreover, the materials used for constructing microchip substance delivery devices are preferably materials that are biocompatible or which can otherwise be made biocompatible by coating the materials with suitable biocompatible materials.
For example, the substrate 102 can be formed using any standard semiconductor material such as silicon, glass, ceramic, etc., which can be machined and etched using standard etching processes (e.g., deep reactive ion etching) and wafer thinning processes, for example. The substrate 102 is formed using a biocompatible material, such as silicon, which is not permeable to the liquid contents contained in the etched cavities and bodily fluids of an individual. The dimensions of the cavity 104 and the number of cavities formed in the substrate 102 will vary depending on the application. In one embodiment of the invention, the cavities are circular-shaped cavities that are formed in a silicon substrate using a deep RIE process. In other embodiments, the cavities can be rectangular-shaped. However, with rectangular-shaped cavities, there can be significant surface tension in the corner wall regions of the cavities, whereby the surface area of such corner wall regions may not “wet” well when filling the cavities with liquid content, thereby resulting in the formation of air bubbles along the corner wall regions of the cavities. On the other hand, a circular-shaped cavity eliminates such corner regions and facilities the cavity filling process.
The stack of insulating layers 110 (or BEOL structure) can be formed on the surface 106 of the substrate 102 using standard semiconductor BEOL fabrication processes. The BEOL 110 can be formed to include metal traces that connect the electrode structure 140 with control circuitry that is integrally formed on the microchip substance delivery device 100. The seal 130 can be fabricated using different types of suitable materials and structures. For example, in one embodiment of the invention, referring to
In one embodiment of the invention, the cavities in the substrate 102 are filled with a deliverable substance prior to the sealing process wherein the membrane 120 is bonded to the substrate 102 via the seal 130. In such instances, the sealing process implemented is one that does not adversely affect or otherwise disturb or degrade the deliverable substance which is filled within the cavities.
In one embodiment of the invention, as noted above, the membrane 120 comprises alternating layers of insulating materials, e.g., silicon dioxide and silicon nitride, which can be fabricated using a standard BEOL process. For example, the membrane 120 is formed on a handler substrate using standard BEOL and copper damascene processes to deposit the insulating layers and form the electrode elements that are embedded within the membrane 120. The membrane 120 can then be transferred to the substrate 102 using a standard wafer transfer/debonding process, and sealed to the substrate 102 using a suitable sealing process to form the seal 130, as discussed above. The silicon nitride films 122 and 124 can be formed in a pre-stressed state, e.g., tensile stress or other suitable stress pattern, to provide the desired stresses that facilitate rupturing of the membrane using actuation mechanisms as described herein.
In other embodiments of the invention, depending on the application, the membrane can be formed with other low thermal conductive, and flexible materials such as polymer materials, which can rupture at specific points that are subjected to highly localized heating, using techniques as described herein. In such embodiments, one or more thin, stressed layers of metallic material can be formed as part of the membrane structure to impart a desired tensile stress (or other stress patterns) to facilitate rupturing of the membrane via a “peel back” force imparted on the membrane due to the stressed metallic layers. In such embodiments, insulating layers would be formed as part of the membrane, as necessary, to electrically isolate the stressed metallic layers from the electrode elements.
As specifically shown in
For example, as shown in
As shown in
More specifically, in the example embodiment of
In one embodiment of the invention, the voids within the linear arrays of voids 212 and 214 are formed at a pitch roughly twice that of the size of each perforation. The location of the void lines 212/214 can be made as close to the edge of the V-shaped electrode 142/144 as that which can be precisely formed using photolithography and reactive ion etching. For good thermal conduction, it is preferred that the void lines 212/214 are separated from the inner edge of the V-shaped electrode 142/1442 by a distance less than 2 times the thickness of the membrane 120.
More specifically, in the example embodiment shown in
When a control voltage is applied to the first and second electrodes 410 and 412, a high current density flows through the fuse portion 414 causing the fuse portion 414 to melt or otherwise break. Moreover, a localized heating of the membrane region surrounding the fuse portion 414, coupled with the existence of voids in the locally heated region of the membrane, collective results in a mechanical stress force that facilitates rupturing of the membrane in the locally heated region of the membrane. Thereafter, the tensile stress present in the first and second electrodes 410 and 412 results in a force that causes the first and second electrodes 410 and 412 to peel back and propagate a rupture in the membrane ling the lines of voids 420 and 422 disposed along the edges of the triangular-shaped electrode portions 410A and 412A.
In one embodiment of the invention as specifically shown in
In one embodiment of the invention as shown in
In one embodiment of the invention, the successive melting of the fuse portions starting from the fuse portion 610A of the central filament 610 causes rupturing of the membrane from the central region of the cavity 104 to the perimeter of the cavity 104. In one embodiment of the invention, the filaments 606, 608, 610, 612 and 614 can be formed in a tensile stressed state such that the breaking of the fuse portions and rupturing of the membrane allows the filaments 606, 608, 610, 612 and 614 to peel back away from the fuse regions and apply a secondary force to assist in rupturing of the membrane.
In another embodiment of the invention, as shown in
In yet another embodiment of the invention, to further facilitate rupturing of the membrane, the low-power electromechanical release mechanism 600 of
In another embodiment of the invention, as shown in
In operation, when a control voltage is applied to the contacts 702, 704, 706 and 708 (with the polarities as shown), a high current density is initially created at a central region of the electrode structure, causes the innermost circular filament 710 to melt and begin the rupturing of the membrane due to various mechanical stress mechanisms as discussed herein. Thereafter, the current density is distributed to successively melt the portions of the circular filaments 712, 714, 716, and 718, disposed between the contacts 702, 704, 706 and 708. In an embodiment in which the radial void lines 720, 722, 724, and 726 are implemented, rupturing of the membrane is propagated along the defined radial lines as the circular fuse portions 710, 712, 714, 716 and 718 successively melt.
As specifically shown in
In particular, in the embodiment of
Furthermore, the mechanical force E that is exerted on the membrane 120 due to the thermal expansion of the electrode structure 840/842/844 further facilitates rupturing of the membrane 120 along the line of weakness provided by the circular line of voids 810 in the locally heated region of the membrane. The groove 820 formed in the membrane 120 provides a gap that allows the membrane 120 to be stretched in the direction of the thermal expansion (indicated by the arrow E) to facilitate the rupturing of the membrane along the circular line of voids 810.
In other embodiments of the invention, low-power electromechanical release mechanisms are configured to melt or otherwise rupture the seal (as opposed to the membrane) to release the contents of the cavities. Example embodiments of release mechanisms that are based on melting or breaking a seal will now be discussed with reference to
More specifically, in the embodiment of
In another embodiment of the invention, the low-power electromechanical release mechanism 900 of
The microchip substance delivery device 1200 further comprises a mechanical stop 1210 (or pedestal) formed on the surface 106 of the substrate 102 and disposed along a portion of an outer perimeter region of the membrane 1220. In one embodiment, the mechanical stop 1210 is coupled to the membrane 1120 using an interface material layer 1212. Furthermore, a seal 1230 and pedestal structure 1232 are formed on the surface 106 of the substrate 102 in proximity to, and surrounding the cavity 104. The seal 1230 is bonded to the membrane 1220 and the pedestal structure 1232 using interface material layers 1234 and 1236, respectively. As with previously discussed embodiments, the seal 1230 and membrane 1220 configured to enclose the cavity 104 and retain a substance 108 within the cavity 104.
In one embodiment, the mechanical stop 1210 and pedestal 1232 structures are formed of metallic materials such as copper, nickel or aluminum, for example. In another embodiment, the mechanical stop 1210 and pedestal 1232 structures are formed of polymer materials (e.g., epoxy, plastic, photopolymer, etc.). In one embodiment of the invention, the interface material layer 1212 is formed of a low adhesive material such as a polymer or Teflon or a weakly adhering material such as Rh or Zn. Further, in one embodiment of the invention, the interface material layers 1234 and 1236 are formed of metallic materials such as Ni, CuNi, NiFe, Al, etc. The seal layer 1230 can be formed of a metallic material such as In or Sn or an alloy comprising In and other metallic material.
The microchip substance delivery device 1200 further comprises an electrode structure 1240/1242/1244 comprising first and second contacts 1242 and 1244, and a semi-circular electrode 1240 formed on the surface 106 of the substrate 102 between the mechanical stop 1210 and the pedestal 1232. A low-adhesion polymer material 1250 encapsulates the semi-circular electrode 1240. In one embodiment, the low-adhesion polymer material 1250 comprises volatile elements such as water, alcohol or other organic materials.
In general, the embodiment of
In one embodiment of the invention, this localized heating results in a thermal expansion of the materials in the region surrounding the semi-circular electrode 1240, in particular, a thermal expansion portion of the membrane 1220 disposed in proximity to the semi-circular electrode 1240. Such thermal expansion results in the generation of mechanical shear stresses that are exerted on the seal 1230 and the interface layers 1212, 1234 and 1236. The interface layers 1212, 1234 and 1236 are configured to mechanically fail and break as a result of the mechanical shear stress, and thereby effectively to break at least a portion of the seal 1230 in proximity to the semi-circular electrode 1240 and release the substance 108 from within the cavity 104.
In another embodiment of the invention, when the low-adhesion polymer material 1250 is formed with volatile components, the polymer material 1250 is configured to release the volatile components in response to the localized heating of the polymer material 1250 by the semi-circular electrode 1240. The release of the volatile components from the polymer material 1250 causes an increase in pressure in the encapsulated region surrounding the semi-circular electrode 1240, which generates a force that is sufficient to break the interface layers 1234 and/or 1236.
In the embodiment shown in
As more specifically shown in
In the embodiment of
In another embodiment of the invention, the metallic membrane structure 1310 is formed of a highly stressed metallic material that is configured to crack as a result of additional mechanical stress applied to the metallic membrane structure 1310 when heated due to current flowing through the metallic membrane structure 1310. In this embodiment, the mechanical cracking of the metallic membrane structure 1310, coupled with the mechanical cracking of the portion of the membrane in which the voids 1320 and 1322 are formed, provides an effective actuation mechanism to mechanically rupture the membrane 120 in the region between the electrodes 1342, 1344, 1346, without necessarily melting the metallic membrane structure 1310.
As more specifically shown in
The microprocessor 1502 generates control signals to the demultiplexer circuitry 1520 to selectively activate one or more releasable membrane structures of the dispensing array 1512. The microprocessor 1502 can generate control signals to activate substance release according to a programmed scheduled stored in the programmable ROM 1504. In another embodiment, the microprocessor 1502 can generate control signals to activate substance release according to control signals output from one or more biosensors 1506 which automatically detect when doses of a given drug or medication are to be administered via activation of one or more releasable membrane structures. In yet another embodiment, the microprocessor 1502 can generate control signals to activate substance release according to control signals output from a wireless receiver based on remote commands provided by the doctor or individual using or controlling the microchip substance delivery device.
In one embodiment of the invention, the power source 1520 can be implemented as an internal power source, such as a bio-compatible thin-film battery, that is integrated with the microchip substance delivery device. For this application, battery size, material, and packaging requirements limit the energy capacity, and it is for this reason that the energy requirements for substrate release are preferably minimized using low-power electromechanical release mechanisms according to embodiments of the invention. In other embodiments, the power source 1520 can be implemented as a wireless power delivery system in which the power is transmitted to the control system 1500 from an external source.
It is to be understood that electromechanical substance delivery devices described herein can be utilized in various types of drug delivery applications. For example, an electromechanical substance delivery device can be positioned in a target location within an individual's body by implantation (e.g., under skin, near tear duct, etc.). Implantation is beneficial when the electromechanical substance delivery device is to remain within the body to administer multiple doses of drugs/medications over a relatively long period of time. In other applications, an electromechanical substance delivery device can be implemented as part of an ingestible device (e.g., swallowable pill) which can be swallowed by an individual. In this application, drug delivery can be provided over a shorter time period that it takes for the ingestible device to pass through the individual's digestive tract. Moreover, in other applications, an electromechanical substance delivery device can be implemented as a wearable device (e.g., a transdermal device or a component of a transdermal device) that is configured to deliver drugs through an individual's skin.
Although embodiments have been described herein with reference to the accompanying drawings for purposes of illustration, it is to be understood that the present invention is not limited to those precise embodiments, and that various other changes and modifications may be affected herein by one skilled in the art without departing from the scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
3993071 | Higuchi et al. | Nov 1976 | A |
4917895 | Lee et al. | Apr 1990 | A |
4941205 | Horst et al. | Jul 1990 | A |
5366454 | Currie et al. | Nov 1994 | A |
5474529 | Arenberg | Dec 1995 | A |
5606323 | Heinrich et al. | Feb 1997 | A |
5912632 | Dieska et al. | Jun 1999 | A |
6068853 | Giannos et al. | May 2000 | A |
6243013 | Duan et al. | Jun 2001 | B1 |
6334859 | Richter | Jan 2002 | B1 |
6436853 | Lin | Aug 2002 | B2 |
6551838 | Santini, Jr. et al. | Apr 2003 | B2 |
6593845 | Friedman et al. | Jul 2003 | B1 |
6703921 | Wuidart et al. | Mar 2004 | B1 |
6773429 | Sheppard, Jr. et al. | Aug 2004 | B2 |
6831548 | Eber et al. | Dec 2004 | B1 |
6849463 | Santini, Jr. et al. | Feb 2005 | B2 |
6875208 | Santini, Jr. et al. | Apr 2005 | B2 |
6953455 | Cho et al. | Oct 2005 | B2 |
6969382 | Richter | Nov 2005 | B2 |
7001372 | Richter | Feb 2006 | B2 |
7070592 | Santini, Jr. et al. | Jul 2006 | B2 |
7114312 | Coppeta et al. | Oct 2006 | B2 |
7226442 | Sheppard, Jr. et al. | Jun 2007 | B2 |
7260371 | Yones | Aug 2007 | B1 |
7372359 | Wuidart et al. | May 2008 | B2 |
7455667 | Uhland | Nov 2008 | B2 |
7473248 | Santini, Jr. et al. | Jan 2009 | B2 |
7510551 | Uhland et al. | Mar 2009 | B2 |
7534241 | Coppeta et al. | May 2009 | B2 |
7563255 | Adamis et al. | Jul 2009 | B2 |
7587190 | Balachandran et al. | Sep 2009 | B2 |
7598864 | Sugimura et al. | Oct 2009 | B2 |
7642918 | Kippelen et al. | Jan 2010 | B2 |
7652313 | Ellis-monaghan et al. | Jan 2010 | B2 |
7652557 | Kantrowitz et al. | Jan 2010 | B2 |
7791481 | Landt et al. | Sep 2010 | B2 |
7901397 | Santini, Jr. et al. | Mar 2011 | B2 |
7910151 | Uhland et al. | Mar 2011 | B2 |
7983565 | Varshneya et al. | Jul 2011 | B2 |
8083710 | Hood et al. | Dec 2011 | B2 |
8095197 | Santini, Jr. et al. | Jan 2012 | B2 |
8205800 | Addy | Jun 2012 | B2 |
8211092 | Uhland et al. | Jul 2012 | B2 |
8273610 | Or-Bach et al. | Sep 2012 | B2 |
8369786 | Witschnig et al. | Feb 2013 | B2 |
8477015 | Pai | Jul 2013 | B1 |
8924023 | Akpan | Dec 2014 | B2 |
9042281 | Miller et al. | May 2015 | B2 |
9108006 | Jensen et al. | Aug 2015 | B2 |
9734371 | Friedman et al. | Aug 2017 | B2 |
9755701 | Friedman et al. | Sep 2017 | B2 |
9937124 | Chey et al. | Apr 2018 | B2 |
10286198 | Dang et al. | May 2019 | B2 |
20010004236 | Letkomiller et al. | Jun 2001 | A1 |
20010051766 | Gazdzinski | Dec 2001 | A1 |
20030175354 | Drizen et al. | Sep 2003 | A1 |
20030198474 | Mooney et al. | Oct 2003 | A1 |
20040020173 | Cho | Feb 2004 | A1 |
20040062556 | Kubo et al. | Apr 2004 | A1 |
20040106914 | Coppeta et al. | Jun 2004 | A1 |
20040106953 | Yomtov et al. | Jun 2004 | A1 |
20040166140 | Santini, Jr. | Aug 2004 | A1 |
20040230182 | Heruth et al. | Nov 2004 | A1 |
20050001724 | Heinrich et al. | Jan 2005 | A1 |
20050050859 | Coppeta | Mar 2005 | A1 |
20050055014 | Coppeta et al. | Mar 2005 | A1 |
20050061870 | Stockton | Mar 2005 | A1 |
20050096587 | Santini, Jr. et al. | May 2005 | A1 |
20050143715 | Cima et al. | Jun 2005 | A1 |
20050152261 | Kahlman | Jul 2005 | A1 |
20050206504 | Sugimura et al. | Sep 2005 | A1 |
20050240370 | Diorio et al. | Oct 2005 | A1 |
20060024358 | Santini, Jr. | Feb 2006 | A1 |
20060057737 | Santini, Jr. | Mar 2006 | A1 |
20060105275 | Maloney | May 2006 | A1 |
20060115323 | Coppeta | Jun 2006 | A1 |
20060127097 | Obrea et al. | Jun 2006 | A1 |
20060222134 | Eldredge et al. | Oct 2006 | A1 |
20060248576 | Levinson | Nov 2006 | A1 |
20060284770 | Jo et al. | Dec 2006 | A1 |
20070015549 | Hernandez et al. | Jan 2007 | A1 |
20070050683 | Attinella et al. | Mar 2007 | A1 |
20070096880 | Nagai | May 2007 | A1 |
20070103311 | Kippelen et al. | May 2007 | A1 |
20070230322 | Morita | Oct 2007 | A1 |
20070253137 | Maloney | Nov 2007 | A1 |
20070273485 | Balachandran et al. | Nov 2007 | A1 |
20080042043 | Reime et al. | Feb 2008 | A1 |
20080088417 | Smith et al. | Apr 2008 | A1 |
20080094245 | Hardacker et al. | Apr 2008 | A1 |
20080154230 | Subramony et al. | Jun 2008 | A1 |
20080231458 | Fein | Sep 2008 | A1 |
20080244273 | Chen et al. | Oct 2008 | A1 |
20090099553 | Langereis | Apr 2009 | A1 |
20090202254 | Majumdar et al. | Aug 2009 | A1 |
20090275925 | Langereis | Nov 2009 | A1 |
20090294535 | Paeschke et al. | Dec 2009 | A1 |
20090306633 | Trovato et al. | Dec 2009 | A1 |
20100061734 | Knapp | Mar 2010 | A1 |
20100128749 | Amann et al. | May 2010 | A1 |
20100182160 | Lu | Jul 2010 | A1 |
20100328043 | Jantunen et al. | Dec 2010 | A1 |
20110053503 | Witschnig et al. | Mar 2011 | A1 |
20110108616 | Wang | May 2011 | A1 |
20110163852 | Kanda et al. | Jul 2011 | A1 |
20110188800 | Futami | Aug 2011 | A1 |
20110205134 | Blumberg, Jr. | Aug 2011 | A1 |
20110215156 | Johnson, II et al. | Sep 2011 | A1 |
20110318013 | Primm | Dec 2011 | A1 |
20120013446 | Ino | Jan 2012 | A1 |
20120032785 | Kamata | Feb 2012 | A1 |
20120153910 | Bulzacchelli et al. | Jun 2012 | A1 |
20120161338 | Lowenthal et al. | Jun 2012 | A1 |
20120234922 | Sample et al. | Sep 2012 | A1 |
20120245565 | Shachar et al. | Sep 2012 | A1 |
20120294625 | Dynes et al. | Nov 2012 | A1 |
20130030763 | Mazzillo | Jan 2013 | A1 |
20130106607 | Clement et al. | May 2013 | A1 |
20130150689 | Shaw-Klein | Jun 2013 | A1 |
20130206837 | Szu | Aug 2013 | A1 |
20130216219 | Honda et al. | Aug 2013 | A1 |
20130285795 | Virtanen et al. | Oct 2013 | A1 |
20140015642 | White | Jan 2014 | A1 |
20140016945 | Pan | Jan 2014 | A1 |
20140022057 | Trosper | Jan 2014 | A1 |
20140296773 | Bulent et al. | Oct 2014 | A1 |
20140332663 | Zecri | Nov 2014 | A1 |
20150102908 | Griesmann et al. | Apr 2015 | A1 |
20150162984 | Liu et al. | Jun 2015 | A1 |
20150227766 | Koezuka et al. | Aug 2015 | A1 |
20150272830 | Iordanov et al. | Oct 2015 | A1 |
20150310715 | Nekoogar et al. | Oct 2015 | A1 |
20150382425 | Lewis et al. | Dec 2015 | A1 |
20160074323 | Chey et al. | Mar 2016 | A1 |
20160117583 | Butler et al. | Apr 2016 | A1 |
20160119059 | Chandra et al. | Apr 2016 | A1 |
20160242124 | Zhou et al. | Aug 2016 | A1 |
20160292470 | Friedman et al. | Oct 2016 | A1 |
20160294481 | Friedman et al. | Oct 2016 | A1 |
20170105260 | Ho et al. | Apr 2017 | A1 |
20170119960 | Dang et al. | May 2017 | A1 |
20170140182 | Mizuno | May 2017 | A1 |
20170147915 | Butler et al. | May 2017 | A1 |
20170228568 | Friedman et al. | Aug 2017 | A1 |
20170272125 | Friedman et al. | Sep 2017 | A1 |
20170325746 | Niichel et al. | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
201725352 | Jan 2011 | CN |
202600746 | Dec 2012 | CN |
202711296 | Jan 2013 | CN |
203562013 | Apr 2014 | CN |
103955736 | Jul 2014 | CN |
2013061888 | Apr 2013 | JP |
20090098472 | Sep 2009 | KR |
2008091826 | Jul 2008 | WO |
2009064402 | May 2009 | WO |
2009107136 | Sep 2009 | WO |
Entry |
---|
E.E. Nuxoll et al., “BioMEMS Devices for Drug Delivery,” IEEE Engineering in Medicine and Biology Magazine, Jan./Feb. 2009, pp. 31-39. |
Knowles, “New Product: Ultrasonic MEMS Microphone,” http://www.knowles.com/eng/Newsroom/New-product-Ultrasonic-MEMS-Microphone, Feb. 1, 2016, 2 pages. |
R. Colin Johnson, “MEMS Mics Taking Over, Tasks Once Performed by Specialized Chips,” EETimes, http://www.eetimes.com/document.asp?doc_id=1324827, Dec. 2, 2014, 3 pages. |
Focused Ultrasound Foundation, “Overview,” http://www.fusfoundation.org/the-technology/overview, Feb. 1, 2016, 2 pages. |
S. Roy et al., “RFID: From Supply Chains to Sensor Nets,” Proceedings of the IEEE, Jul. 2010, pp. 1583-1592, vol. 98, No. 9. |
M. Buckner et al., “GPS and Sensor-Enabled RFID Tags,” Unclassified Document, Oak Ridge National Laboratory, http://www.oml.gov/webworks/cppr/y2001/pres/118169.pdf, 2001, 5 pages. |
A.P. Sample et al., “Design of a Passively-Powered, Programmable Sensing Platform for UHF RFID Systems,” IEEE International Conference on RFID, Mar. 2007, pp. 149-156. |
J. M. Maloney et al., “Electrothermally Activated Microchips for Implantable Drug Delivery and Biosensing,” Science Direct, Journal of Controlled Release vol. 109, Issues 1-3, Dec. 2005, pp. 244-255. |
L. Hu et al., “A Composite Thermo-Responsive Membrane System for Improved Controlled-Release,” Chemical Engineering & Technology, vol. 30, No. 4, 2007, pp. 523-529. |
Fritz et al., “Thresholds for Igniting Exothermic Reactions in Al/Ni Multilayers Using Pulses of Electrical, Mechanical, and Thermal Energy,” Jorunal of Applied Physics, vol. 113, No. 1, 2013, 12 pages. |
Number | Date | Country | |
---|---|---|---|
20180133152 A1 | May 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14483278 | Sep 2014 | US |
Child | 15852943 | US |